| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 700405 | 108469035 | Oprymea 1,05 mg comprimidos de liberacion prolongada EFG | Oprymea 1,05 mg comprimidos de liberacion prolongada EFG 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/108469035/108469035_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/108469035/108469035_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2013-11-21 | 1 | 1 | 1 | 2013-11-21 | 2013-11-21 | 0 | 2014-02-03 | View Edit Delete | ||||||||||||
| 700178 | 78138 | PRAMIPEXOL TARBIS 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PRAMIPEXOL TARBIS 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78138/78138_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78138/78138_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2013-10-28 | 1 | 1 | 1 | 2013-10-28 | 2013-10-28 | 0 | 2014-02-19 | View Edit Delete | ||||||||||||
| 699416 | 77912 | PRAMIPEXOL TEVA 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PRAMIPEXOL TEVA 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77912/77912_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77912/77912_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2013-10-17 | 1 | 1 | 1 | 2013-10-17 | 2013-10-24 | 0 | 2014-01-31 | View Edit Delete | ||||||||||||
| 700167 | 78127 | PRAMIPEXOL RATIOPHARM 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PRAMIPEXOL RATIOPHARM 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78127/78127_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78127/78127_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2013-10-28 | 1 | 1 | 1 | 2013-10-28 | 2013-10-28 | 0 | 2014-01-31 | View Edit Delete | ||||||||||||
| 700171 | 78131 | PRAMIPEXOL SANDOZ FARMACEUTICA 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PRAMIPEXOL SANDOZ FARMACEUTICA 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78131/78131_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78131/78131_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2013-10-28 | 1 | 1 | 1 | 2013-10-28 | 2013-10-28 | 0 | 2014-02-10 | View Edit Delete | ||||||||||||
| 700356 | 78197 | PRAMIPEXOL PENSA 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PRAMIPEXOL PENSA 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78197/78197_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78197/78197_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2013-11-14 | 1 | 1 | 1 | 2013-11-14 | 2013-11-14 | 0 | 2014-02-04 | View Edit Delete | ||||||||||||
| 700100 | 78077 | PRAMIPEXOL AUROVITAS SPAIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PRAMIPEXOL AUROVITAS SPAIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78077/78077_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78077/78077_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2013-10-17 | 1 | 1 | 1 | 2013-10-17 | 2013-10-17 | 0 | 2014-01-30 | View Edit Delete | ||||||||||||
| 707139 | 80053 | PRAMIPEXOL CINFA 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PRAMIPEXOL CINFA 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80053/80053_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80053/80053_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2015-07-24 | 1 | 1 | 1 | 2015-07-24 | 2015-07-24 | 0 | 2015-10-09 | View Edit Delete | ||||||||||||
| 763463 | 97051020IP | MIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA | MIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97051020IP/97051020IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97051020IP/97051020IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | ELAM PHARMA LABS S.L. | 2023-09-29 | 1 | 1 | 1 | 2023-09-30 | 2023-09-29 | 0 | 2024-05-20 | View Edit Delete | ||||||||||||
| 766404 | 97051020IP3 | MIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA | MIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97051020IP3/97051020IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97051020IP3/97051020IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | ECOFAR PRODUCTOS S.L. | 2024-12-03 | 1 | 1 | 1 | 2024-12-04 | 2024-12-03 | 0 | 2025-01-21 | View Edit Delete | ||||||||||||
| 765615 | 97051020IP1 | MIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA | MIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97051020IP1/97051020IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97051020IP1/97051020IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | ABACUS MEDICINE A/S | 2024-08-22 | 1 | 1 | 1 | 2024-08-23 | 2024-08-22 | 0 | 2024-10-04 | View Edit Delete | ||||||||||||
| 767995 | 97051020IP4 | MIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA | MIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 1,05 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97051020IP4/97051020IP4_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97051020IP4/97051020IP4_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | MELYFARMA S.L. | 2025-06-26 | 1 | 1 | 1 | 2025-06-27 | 2025-06-26 | 0 | 2025-12-12 | View Edit Delete | ||||||||||||
| 716187 | 1151062001 | RAVICTI 1,1 G/ML LIQUIDO ORAL | RAVICTI 1,1 G/ML LIQUIDO ORAL, 1 frasco de 25 ml | 1,1 g/ml | 6 | 25 | 26 | 1 frasco de 25 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151062001/1151062001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151062001/1151062001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 41362 | INFORMACION NO DISPONIBLE | 2017-06-19 | 1 | 1 | 1 | 2017-06-20 | 2017-06-19 | 0 | 2018-03-09 | View Edit Delete | ||||||||||||
| 767618 | 1221631001 | BREYANZI 1,1-70 × 10E6 CELULAS/ML / 1,1-70 × 10E6 CELULAS/ML DISPERSION PARA PERFUSION | BREYANZI 1,1-70 × 10E6 CELULAS/ML / 1,1-70 × 10E6 CELULAS/ML DISPERSION PARA PERFUSION, entre 1 y 4 viales (4,6 ml por vial) | 1,1-70 x 10e6 células/ml/1,1-70 x 10e6 células/ml inyectable perfusión | 45 | 1-4 | 34 | entre 1 y 4 viales (4,6 ml por vial) | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221631001/1221631001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221631001/1221631001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2025-05-08 | 1 | 1 | 1 | 2025-05-09 | 2025-05-08 | 1 | 2026-02-12 | View Edit Delete | ||||||||||||
| 766222 | 1241836001 | GALLIAPHARM 1,11 GBQ GENERADOR DE RADIONUCLIDOS | GALLIAPHARM 1,11 GBQ GENERADOR DE RADIONUCLIDOS, 1 generador de radionúclidos | 1,11 GBq | 92 | 1 | 50 | 1 generador de radionúclidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241836001/1241836001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241836001/1241836001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12588 | NUCLIBER, S.A. | 2024-11-14 | 1 | 1 | 1 | 2024-11-15 | 2024-11-14 | 0 | 2026-05-13 | View Edit Delete | ||||||||||||
| 817601 | 39574 | RHINOSPRAY 1,18 mg/ ml SOLUCION PARA PULVERIZACION NASAL | RHINOSPRAY 1,18 mg/ ml SOLUCION PARA PULVERIZACION NASAL , 1 envase pulverizador de 12 ml | 1,18 mg/ml | 6 | 12 | 26 | 1 envase pulverizador de 12 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/39574/39574_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/39574/39574_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41334 | OPELLA HEALTHCARE SPAIN S.L. | 1964-02-01 | 1 | 1 | 1 | 1964-02-01 | 1964-02-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 965673 | 56731 | RHINOSPRAY EUCALIPTUS 1,18 mg/ ml SOLUCION PARA PULVERIZACION NASAL | RHINOSPRAY EUCALIPTUS 1,18 mg/ ml SOLUCION PARA PULVERIZACION NASAL , 1 envase pulverizador de 10 ml | 1,18 mg/ml | 6 | 10 | 26 | 1 envase pulverizador de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56731/56731_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56731/56731_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41334 | OPELLA HEALTHCARE SPAIN S.L. | 1986-10-01 | 1 | 1 | 1 | 1986-10-01 | 1986-10-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 664979 | 61818 | GENOTONORM MINIQUICK 1,2 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | GENOTONORM MINIQUICK 1,2 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE 7 viales de doble cámara | 1,2 mg | 45 | 7 | 57 | 7 viales de doble cámara | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61818/61818_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61818/61818_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 1998-04-01 | 1 | 1 | 1 | 1998-04-01 | 1998-04-01 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 706500 | 61818 | GENOTONORM MINIQUICK 1,2 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | GENOTONORM MINIQUICK 1,2 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE 28 (4 x 7) viales de doble cámara | 1,2 mg | 45 | 28 | 57 | 28 (4 x 7) viales de doble cámara | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61818/61818_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61818/61818_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 1998-04-01 | 1 | 1 | 1 | 1998-04-01 | 2015-05-19 | 1 | 2015-10-08 | View Edit Delete | ||||||||||||
| 732559 | 1211577003 | VOXZOGO 1,2 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | VOXZOGO 1,2 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 10 viales, 10 jeringas precargadas y 10 jeringas para administracion | 1,2 mg | 80 | 10 | 34 | 10 viales, 10 jeringas precargadas y 10 jeringas para administracion | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211577003/1211577003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211577003/1211577003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 20700 | BIOMARIN PHARMACEUTICALS ESPAÑA S.L. | 2022-01-20 | 1 | 1 | 1 | 2022-01-21 | 2022-01-20 | 1 | 2023-02-09 | View Edit Delete |
Page 75 of 1035, showing 20 records out of 20697 total, starting on record 1481, ending on 1500